ES446637A1 - Acellular vaccines - Google Patents

Acellular vaccines

Info

Publication number
ES446637A1
ES446637A1 ES446637A ES446637A ES446637A1 ES 446637 A1 ES446637 A1 ES 446637A1 ES 446637 A ES446637 A ES 446637A ES 446637 A ES446637 A ES 446637A ES 446637 A1 ES446637 A1 ES 446637A1
Authority
ES
Spain
Prior art keywords
acellular vaccines
bacteria
acellular
vaccines
ark
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES446637A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre SA
Original Assignee
Pierre Fabre SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre SA filed Critical Pierre Fabre SA
Publication of ES446637A1 publication Critical patent/ES446637A1/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0266—Klebsiella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0283—Shigella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Procedure for the preparation of acellular vaccines, characterized in that the ribonucleic acid (ark) of the germ or bacteria corresponding to the vaccine is mixed with lipopolysaccharides and membrane polysaccharides extracted from bacteria. (Machine-translation by Google Translate, not legally binding)
ES446637A 1975-04-02 1976-04-02 Acellular vaccines Expired ES446637A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7510252A FR2305990A1 (en) 1975-04-02 1975-04-02 PREPARATION OF VACCINES BASED ON RNA NUCLEIC ACIDS ASSOCIATED WITH POLYSACCHARIDES EXTRACTED FROM MICROBIAL GERMS

Publications (1)

Publication Number Publication Date
ES446637A1 true ES446637A1 (en) 1977-06-01

Family

ID=9153417

Family Applications (1)

Application Number Title Priority Date Filing Date
ES446637A Expired ES446637A1 (en) 1975-04-02 1976-04-02 Acellular vaccines

Country Status (6)

Country Link
JP (1) JPS51121511A (en)
BE (1) BE839893A (en)
DE (1) DE2613943C3 (en)
ES (1) ES446637A1 (en)
FR (1) FR2305990A1 (en)
GB (1) GB1543962A (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2253499B1 (en) * 1973-12-10 1977-11-04 Fabre Sa Pierre
FR2444464A1 (en) 1978-12-19 1980-07-18 Fabre Sa Pierre PURIFIED BACTERIAL PROTEOGLYCANS, PROCESS FOR THEIR PREPARATION AND VACCINE CONTAINING THEM
FR2471785A1 (en) * 1979-12-21 1981-06-26 Fabre Sa Pierre RIBOSOMAL RNA-BASED IMMUNOSTIMULANT PREPARATIONS AND PROCESS FOR THE PREPARATION OF RNA
FR2475900A1 (en) * 1980-02-20 1981-08-21 Fabre Sa Pierre VACCINE COMPLEX CONTAINING A SPECIFIC ANTIGEN AND VACCINE CONTAINING SAME
FR2596064B1 (en) * 1986-03-18 1990-02-02 Pf Medicament INDUSTRIAL PROCESSES FOR THE MANUFACTURE OF RIBOSOMAL VACCINES AND RIBOSOMAL VACCINES OBTAINED
AR055311A1 (en) 2006-02-17 2007-08-15 H P B S A SOLID PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PROSTATE BENIGN HYPERPLASIA, PROCEDURE FOR THEIR ELABORATION AND TREATMENT METHOD

Also Published As

Publication number Publication date
BE839893A (en) 1976-09-22
GB1543962A (en) 1979-04-11
DE2613943B2 (en) 1979-07-05
DE2613943C3 (en) 1980-03-06
JPS51121511A (en) 1976-10-23
FR2305990A1 (en) 1976-10-29
FR2305990B1 (en) 1980-01-25
DE2613943A1 (en) 1976-10-14

Similar Documents

Publication Publication Date Title
BE866464A (en) ADVANCED ACELLULAR VACCINES CONTAINING CAPSULAR POLYSACCHARIDES.
ES481108A1 (en) Inula extract, process for preparing it and its use as a medicament.
ES446637A1 (en) Acellular vaccines
ES419996A1 (en) Vaccine for neonatal calf diarrhoea
JPS5242483A (en) Emulsion stabilizing agent
JPS5435285A (en) Preparation of l-threonine by fermentation
ES266270A1 (en) Benzyl alcohol stabilized polio vaccines and production thereof
ES413090A1 (en) Isolating rubbers
ES294348A1 (en) Procedure for preparing new products for skin care (Machine-translation by Google Translate, not legally binding)
ES313319A1 (en) Procedure for the preparation of a vaccine against tuberculosis. (Machine-translation by Google Translate, not legally binding)
ES389874A1 (en) Apparatus for sterilizing compressed air
ES313427A1 (en) A method for the preparation of a vaccine of brucella abortus living. (Machine-translation by Google Translate, not legally binding)
ES255146A3 (en) Method of preparation of effective immunizing antigens in vaccination of cattle (Machine-translation by Google Translate, not legally binding)
JPS527488A (en) Preparation of l-threonine by fermentation
ES458389A1 (en) 8-azaprostaglandins and process for the preparation thereof
ES266340A1 (en) Myristyl-gamma-picolinium chloride preserved polio vaccine and its production
DE2961506D1 (en) N-cyclohexyl-n-methoxy-acetoacetamide, process for its preparation and its use to prepare o-methyl-n-cyclohexyl-2,5-dimethyl-furane-3-hydroxamic acid
ES444580A1 (en) Process for preserving pharmaceutical compositions and the compositions prepared thereby
ES371843A1 (en) Process for the manufacture of a vaccine
ES476147A1 (en) Antigenic complex from neisseria gonorrhoeae, process and vaccine.
ES437426A1 (en) Procedure for the preparation of a substance with immune effect. (Machine-translation by Google Translate, not legally binding)
AU216361B2 (en) Poliomyelitis virus vaccine and method of producing thesame
ES239963A1 (en) A method for the production of appropriate vaccines for their oral administration to domestic animals (Machine-translation by Google Translate, not legally binding)
AU1668156A (en) Poliomyelitis virus vaccine and method of producing thesame
ES260718A1 (en) Procedure for the obtaining of a vaccine against the contagious fever of dogs (febris contagiosa canum) (Machine-translation by Google Translate, not legally binding)

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970222